US Broker Ratings

Pfizer, Inc. (PFE): Investor Outlook Reveals 17.54% Potential Upside Amid Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE), a heavyweight in the healthcare sector, presents an intriguing opportunity for investors with its substantial market capitalization of $139.35 billion and its..

Mettler-Toledo International (MTD): Navigating Valuation with a Market Cap of $27.79 Billion

Mettler-Toledo International Inc. (NYSE: MTD) is a formidable player in the diagnostics and research sector, boasting a market capitalization of $27.79 billion. Based in Columbus, Ohio,..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

Medtronic plc (MDT) Investor Outlook: Exploring a 5.46% Potential Upside Amid Robust Revenue Growth

Medtronic plc (MDT), a prominent player in the healthcare sector, is a household name in the medical devices industry. Headquartered in Galway, Ireland, Medtronic has established..

The Cigna Group (CI) Stock Analysis: Exploring a 22.46% Potential Upside with Strong Buy Ratings

The Cigna Group (NYSE: CI) is positioned as a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with Impressive Growth and Robust Pipeline

Investors looking for potential high-growth opportunities in the biotech sector might find argenx SE (NASDAQ: ARGX) an intriguing prospect. With a market capitalization of $51.94 billion,..

Stryker Corporation (SYK) Stock Analysis: Exploring a 14.58% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, particularly in the medical devices industry, is attracting significant attention from investors due to its robust..

Takeda Pharmaceutical (TAK) Stock Analysis: Unveiling a 26% Potential Upside Amidst Strong Dividend Yield

Investors seeking opportunities in the healthcare sector might find Takeda Pharmaceutical Company Limited (NYSE: TAK) an appealing candidate, given its potential upside and robust dividend yield...

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 27% Potential Upside Amidst Robust Revenue Growth

For investors keen on capitalizing on the future of healthcare technology, Intuitive Surgical, Inc. (ISRG) presents a compelling opportunity. As a leader in the medical instruments..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 7% Upside Potential in the Healthcare Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent name in the healthcare sector, stands at the forefront of diagnostics and research, focusing on companion animal veterinary, livestock,..

ResMed Inc. (RMD) Stock Analysis: Exploring Growth Potential and Analyst Ratings

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and innovative product offerings. With..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating a 4.33% Upside Potential with Robust Growth

Thermo Fisher Scientific Inc (NYSE: TMO) continues to solidify its position as a leader in the healthcare sector, specifically within the diagnostics and research industry. With..

Bristol-Myers Squibb (BMY) Investor Outlook: Navigating a 21.59% Potential Upside Amidst Strong Dividend Yield

Investors looking at Bristol-Myers Squibb Company (NYSE: BMY) are presented with a unique opportunity within the healthcare sector, especially given its recent financial metrics and analyst..

GSK plc (GSK) Stock Analysis: Analyst Ratings Reveal a Cautious Outlook Amid Solid Dividend Yield

GSK plc (GSK), a titan in the healthcare sector, stands as a prominent player in the drug manufacturing industry with a market capitalization of $88.28 billion...

Vertex Pharmaceuticals (VRTX) Investor Outlook: Analyzing a 15% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a powerhouse in the biotechnology sector, with a particular focus on transformative therapies for cystic fibrosis (CF). With a..

Abbott Laboratories (ABT) Stock Analysis: Evaluating a 12.33% Potential Upside for Investors

Abbott Laboratories (NYSE: ABT) stands as a stalwart in the healthcare sector, particularly in the medical devices industry. With a substantial market capitalization of $223.72 billion,..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 41.82% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has captured investor attention with its promising pipeline and impressive stock performance. Specializing in developing targeted therapies for..

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Player with 7.47% Upside Potential

Septerna, Inc. (NASDAQ: SEPN), a burgeoning player in the biotechnology industry, has piqued the interest of investors with its innovative approach to drug development, targeting G..

Precigen, Inc. (PGEN) Stock Analysis: Unlocking a 136% Upside Potential in Biotech Innovation

Precigen, Inc. (NASDAQ: PGEN) stands as a promising player in the biopharmaceutical sector, capturing investor attention with its cutting-edge gene and cell therapy innovations. Specializing in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating a Complex Diagnostics Landscape with Strategic Collaborations

Investors looking at Myriad Genetics, Inc. (NASDAQ: MYGN) are peering into a company that stands at the intersection of molecular diagnostics and precision medicine, targeting key..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds